MAPLIGHT THERAPEUTICS INC (MPLT) Forecast, Price Target & Analyst Ratings

NASDAQ:MPLT • US56565P1030

Current stock price

17.08 USD
-0.48 (-2.73%)
At close:
17.2 USD
+0.12 (+0.7%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MAPLIGHT THERAPEUTICS INC (MPLT).

Forecast Snapshot

Consensus Price Target

Price Target
$31.62
+ 85.13% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$1.01
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
88.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$31.62
Upside
+ 85.13%
From current price of $17.08 to mean target of $31.62, Based on 10 analyst forecasts
Low
$28.28
Median
$31.62
High
$35.70

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for MPLT. The average price target is 31.62 USD. This implies a price increase of 85.13% is expected in the next year compared to the current price of 17.08.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MPLT Current Analyst RatingMPLT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

MPLT Historical Analyst RatingsMPLT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -3 -2 -1 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
88.00%
MPLT was analyzed by 10 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about MPLT.
In the previous month the buy percentage consensus was at a similar level.
MPLT was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-19Canaccord GenuityInitiate Buy
2025-11-21Leerink PartnersInitiate Outperform
2025-11-21StifelInitiate Buy
2025-11-21Morgan StanleyInitiate Overweight
2025-11-21JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$1.01
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
5.45%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
MPLT revenue by date.MPLT revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
MPLT ebitda by date.MPLT ebitda by date.
-30.671M-56.726M
-84.95%		-82.245M
-44.99%		N/A
-104.46%		N/A
-23.70%		N/A
-7.59%
EBIT
YoY % growth
MPLT ebit by date.MPLT ebit by date.
-31.245M-57.282M
-83.33%		-82.946M
-44.80%		N/A
-66.02%		N/A
-43.32%		N/A
-33.06%
Operating Margin
MPLT operating margin by date.MPLT operating margin by date.
N/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MPLT eps by date.MPLT eps by date.
N/AN/AN/AN/AN/A
41.87%		N/A
-3.05%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.01-0.78
43.70%		-0.92
17.35%		-1.05
97.19%		-1.09
-7.54%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-39.916M
51.88%		-44.268M
-70.20%		-48.96M
9.68%		-54.672M
-43.96%		-61.404M
-53.83%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MPLT Yearly EPS VS EstimatesMPLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-27.50%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-39.22%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MAPLIGHT THERAPEUTICS INC / MPLT Forecast FAQ

Can you provide the average price target for MAPLIGHT THERAPEUTICS INC stock?

10 analysts have analysed MPLT and the average price target is 31.62 USD. This implies a price increase of 85.13% is expected in the next year compared to the current price of 17.08.

Can you provide the consensus estimates for MAPLIGHT THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of MAPLIGHT THERAPEUTICS INC (MPLT) is -1.01 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed MAPLIGHT THERAPEUTICS INC (MPLT)?

The number of analysts covering MAPLIGHT THERAPEUTICS INC (MPLT) is 10.